← Open Payments lookup

REBECCA HARTZOG: Open Payments

NPI 1215267018 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,165 in 152 payments from 16 companies in 2025. Trend: 2023 $2,895 · 2024 $6,890 · 2025 $6,165

Speaker / faculty: $3,375Food & beverage: $2,758Travel & lodging: $32
CompanyPaymentsAmount
ABBVIE INC.29$3,886
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$441
Axsome Therapeutics, Inc.19$337
Teva Pharmaceuticals USA, Inc.8$212
Collegium Pharmaceutical, Inc.12$193
Vanda Pharmaceuticals Inc.11$181
Takeda Pharmaceuticals U.S.A., Inc.10$164
Otsuka America Pharmaceutical, Inc.5$147
Janssen Pharmaceuticals, Inc12$140
Supernus Pharmaceuticals, Inc.6$131

Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, AUSTEDO XR, Jornay PM, FANAPT, TRINTELLIX.

Industry payments across MS — which companies pay providers there.